Brawn Biotech Limited (BOM:530207)
18.60
-0.45 (-2.36%)
At close: Feb 11, 2026
Brawn Biotech Market Cap
Brawn Biotech has a market cap or net worth of 55.81 million as of February 13, 2026. Its market cap has decreased by -11.89% in one year.
Market Cap
55.81M
Enterprise Value
53.91M
Revenue
168.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.60
Market Cap Chart
Since August 11, 2005, Brawn Biotech's market cap has increased from 23.22M to 55.81M, an increase of 140.31%. That is a compound annual growth rate of 4.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 55.81M | -13.53% |
| Dec 31, 2025 | 64.54M | 0.94% |
| Dec 31, 2024 | 63.94M | -2.69% |
| Dec 26, 2023 | 65.71M | 11.17% |
| Dec 30, 2022 | 59.11M | -13.79% |
| Dec 31, 2021 | 68.56M | -6.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rekvina Laboratories | 129.36M |
| Cian Healthcare | 125.23M |
| Beryl Drugs | 110.97M |
| Shamrock Industrial Company | 110.51M |
| Ortin Global | 110.51M |
| Unjha Formulations | 104.35M |
| Vivanza Biosciences | 84.00M |
| Decipher Labs | 82.42M |